Pre-treatment Apparent Diffusion Coefficient Does Not Predict Therapy Response to Radiochemotherapy in Cervical Cancer: A Systematic Review and Meta-analysis
Authors:
- 3 March 2021
- journal article
- review article
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 41 (3) , 1163-1170
Abstract
Background/Aim: Magnetic resonance imaging is used for staging purposes in cervical cancer (CC). Diffusion-weighted imaging and the apparent diffusion coefficient (ADC) are associated with tumor microstructure. The present analysis sought to compare pre-treatment ADC values to predict treatment outcome of radiochemotherapy for CC based upon a large patient sample. Materials and Methods: MEDLINE library and SCOPUS databases were assessed for suitable articles up to May 2020. The primary endpoint was the mean ADC value of CC according to the treatment response to radiochemotherapy. In total, 16 studies were included in the analysis. Results: For the response group, 416 patients were included in the analysis (72.5%) and for the no-response group 158 patients were included (27.5%). The mean ADC value of patients with CC with treatment response was 0.87×10−3 mm2/s (95% confidence interval=0.81-0.94×10−3 mm2/s), and for the patients with no response was 0.92×10−3 mm2/s (95% confidence interval=0.85-0.98×10−3 mm2/s). Conclusion: Pre-treatment ADC values alone cannot be used to reliably predict treatment response to radiochemotherapy in CC.Keywords
This publication has 39 references indexed in Scilit:
- Correlation of Histogram Analysis of Apparent Diffusion Coefficient With Uterine Cervical Pathologic FindingAmerican Journal of Roentgenology, 2015
- Simultaneous changes of magnetic resonance diffusion-weighted imaging and pathological microstructure in locally advanced cervical cancer caused by neoadjuvant chemotherapyJournal of Magnetic Resonance Imaging, 2014
- The value of diffusion-weighted MRI to evaluate the response to radiochemotherapy for cervical cancerMagnetic Resonance Imaging, 2014
- Predictive value of diffusion‐weighted magnetic resonance imaging during chemoradiotherapy for uterine cervical cancerJournal of Obstetrics and Gynaecology Research, 2013
- Pathological response on surgical samples is an independent prognostic variable for patients with Stage Ib2–IIb cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: An Italian multicenter retrospective study (CTF Study)Gynecologic Oncology, 2013
- The Value of Diffusion-Weighted Magnetic Resonance Imaging in Assessing the Response of Locally Advanced Cervical Cancer to Neoadjuvant ChemotherapyInternational Journal of Gynecological Cancer, 2012
- Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital RadiologyEuropean Radiology, 2010
- Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiationClinical Radiology, 2009
- Systematic Reviews of Diagnostic Test AccuracyAnnals of Internal Medicine, 2008
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986